Merck Cost of Goods Sold 2010-2024 | MKKGY

Merck annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Merck cost of goods sold for the quarter ending June 30, 2024 was $2.282B, a 2.16% decline year-over-year.
  • Merck cost of goods sold for the twelve months ending June 30, 2024 was $9.431B, a 5.26% increase year-over-year.
  • Merck annual cost of goods sold for 2023 was $9.308B, a 3.6% increase from 2022.
  • Merck annual cost of goods sold for 2022 was $8.984B, a 3.3% increase from 2021.
  • Merck annual cost of goods sold for 2021 was $8.697B, a 11.39% increase from 2020.
Merck Annual Cost of Goods Sold
(Millions of US $)
2023 $9,308
2022 $8,984
2021 $8,697
2020 $7,808
2019 $6,727
2018 $6,356
2017 $6,013
2016 $5,755
2015 $4,523
2014 $4,688
2013 $3,975
2012 $4,061
2011 $3,884
2010 $
2009 $
Merck Quarterly Cost of Goods Sold
(Millions of US $)
2024-06-30 $2,282
2024-03-31 $2,292
2023-12-31 $2,504
2023-09-30 $2,353
2023-06-30 $2,332
2023-03-31 $2,118
2022-12-31 $2,347
2022-09-30 $2,162
2022-06-30 $2,244
2022-03-31 $2,230
2021-12-31 $2,246
2021-09-30 $2,192
2021-06-30 $2,184
2021-03-31 $2,075
2020-12-31 $2,134
2020-09-30 $2,076
2020-06-30 $1,773
2020-03-31 $1,825
2019-12-31 $1,876
2019-09-30 $1,644
2019-06-30 $1,635
2019-03-31 $1,572
2018-12-31 $1,596
2018-09-30 $1,563
2018-06-30 $1,575
2018-03-31 $1,623
2017-12-31 $1,641
2017-09-30 $1,527
2017-06-30 $1,464
2017-03-31 $1,381
2016-12-31 $1,432
2016-09-30 $1,396
2016-06-30 $1,485
2016-03-31 $1,442
2015-12-31 $1,258
2015-09-30 $1,045
2015-06-30 $1,123
2015-03-31 $1,098
2014-12-31 $1,283
2014-09-30 $1,258
2014-06-30 $1,137
2014-03-31 $1,009
2013-12-31 $1,057
2013-09-30 $958
2013-06-30 $1,003
2013-03-31 $956
2012-12-31
2012-09-30 $985
2012-06-30 $1,038
2012-03-31
2011-12-31
2011-09-30
2011-06-30 $1,094
2011-03-31
2010-12-31
2010-09-30 $799
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $21.306B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
New York Community Bancorp (FLG) United States $4.269B 0.00
Acasti Pharma (GRCE) Canada $0.033B 0.00